Serine-threonine kinases in TCR signaling

Nature Immunology

Volumn 15, Issue 9, 2014, Pages 808-814

  Navarro, María N ^a   Cantrell, Doreen A ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; NUTRIENT SENSING SERINE THREONINE KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; RAS PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

CELL METABOLISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; LYMPHOCYTE ACTIVATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84906221604     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2941     Document Type: Review

References (99)

1. Matthews, S.A. & Cantrell, D.A. New insights into the regulation and function of serine/threonine kinases in T lymphocytes. Immunol. Rev. 228, 241-252 (2009).
2. Rosse, C. et al. PKC and the control of localized signal dynamics. Nat. Rev. Mol. Cell Biol. 11, 103-112 (2010).
3. Weiss, A., Wiskocil, R.L. & Stobo, J.D. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 133, 123-128 (1984).
4. Cantrell, D.A., Davies, A.A. & Crumpton, M.J. Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. Proc. Natl. Acad. Sci. USA 82, 8158-8162 (1985).
5. Monks, C.R., Kupfer, H., Tamir, I., Barlow, A. & Kupfer, A. Selective modulation of protein kinase C-θ during T-cell activation. Nature 385, 83-86 (1997).
6. Dustin, M.L. & Depoil, D. New insights into the T cell synapse from single molecule techniques. Nat. Rev. Immunol. 11, 672-684 (2011).
7. Quann, E.J., Liu, X., Altan-Bonnet, G. & Huse, M. A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells. Nat. Immunol. 12, 647-654 (2011).
8. Jun, J.E., Rubio, I. & Roose, J.P. Regulation of Ras exchange factors and cellular localization of Ras activation by lipid messengers in T cells. Front. Immunol. 4, 239 (2013).
9. Rozengurt, E. Protein kinase D signaling: multiple biological functions in health and disease. Physiology (Bethesda) 26, 23-33 (2011).
10. Carrasco, S. & Merida, I. Diacylglycerol-dependent binding recruits PKCθ and RasGRP1 C1 domains to specific subcellular localizations in living T lymphocytes. Mol. Biol. Cell 15, 2932-2942 (2004).
11. Spitaler, M., Emslie, E., Wood, C.D. & Cantrell, D. Diacylglycerol and protein kinase D localization during T lymphocyte activation. Immunity 24, 535-546 (2006).
12. Huse, M. et al. Spatial and temporal dynamics of T cell receptor signaling with a photoactivatable agonist. Immunity 27, 76-88 (2007).
13. Quann, E.J., Merino, E., Furuta, T. & Huse, M. Localized diacylglycerol drives the polarization of the microtubule-organizing center in T cells. Nat. Immunol. 10, 627-635 (2009).
14. Pearce, L.R., Komander, D. & Alessi, D.R. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9-22 (2010).
15. Matsumoto, R. et al. Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation. Immunity 23, 575-585 (2005).
16. Dustin, M.L. PKC-θ: hitting the bull's eye. Nat. Immunol. 12, 1031-1032 (2011).
17. Liu, X., Kapoor, T.M., Chen, J.K. & Huse, M. Diacylglycerol promotes centrosome polarization in T cells via reciprocal localization of dynein and myosin II. Proc. Natl. Acad. Sci. USA 110, 11976-11981 (2013).
18. Ma, J.S.Y., Haydar, T.F. & Radoja, S. Protein kinase C- localizes to secretory lysosomes in CD8+ CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity. J. Immunol. 181, 4716-4722 (2008).
19. Letschka, T. et al. PKC-θ selectively controls the adhesion-stimulating molecule Rap1. Blood 112, 4617-4627 (2008).
20. Fagerholm, S., Morrice, N., Gahmberg, C.G. & Cohen, P. Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes. J. Biol. Chem. 277, 1728-1738 (2002).
21. Matthews, S.A., Rozengurt, E. & Cantrell, D. Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J. Exp. Med. 191, 2075-2082 (2000).
22. Waldron, R.T. et al. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J. Biol. Chem. 276, 32606-32615 (2001).
23. Rey, O., Reeve, J.R., Zhukova, E., Sinnett-Smith, J. & Rozengurt, E. G protein-coupled receptor-mediated phosphorylation of the activation loop of protein kinase D: dependence on plasma membrane translocation and protein kinase C?. J. Biol. Chem. 279, 34361-34372 (2004).
24. Matthews, S.A. et al. Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells. Biochem. J. 432, 153-163 (2010).
25. Navarro, M.N. et al. Protein kinase D2 has a restricted but critical role in T-cell antigen receptor signalling in mature T-cells. Biochem. J. 442, 649-659 (2012).
26. Fischer, A.M., Katayama, C.D., Pagès, G., Pouysségur, J. & Hedrick, S.M. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23, 431-443 (2005).
27. D'Souza, W.N., Chang, C.-F., Fischer, A.M., Li, M. & Hedrick, S.M. The Erk2 MAPK regulates CD8 T cell proliferation and survival. J. Immunol. 181, 7617-7629 (2008).
28. Costello, P.S., Nicolas, R.H., Watanabe, Y., Rosewell, I. & Treisman, R. Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection. Nat. Immunol. 5, 289-298 (2004).
29. Wagner, E.F. & Eferl, R. Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208, 126-140 (2005).
30. Owens, D.M. & Keyse, S.M. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26, 3203-3213 (2007).
31. Lovrić , J., Dammeier, S., Kieser, A., Mischak, H. & Kolch, W. Activated raf induces the hyperphosphorylation of stathmin and the reorganization of the microtubule network. J. Biol. Chem. 273, 22848-22855 (1998).
32. Lin, J.-X., Spolski, R. & Leonard, W.J. Critical role for Rsk2 in T-lymphocyte activation. Blood 111, 525-533 (2008).
33. Romeo, Y., Zhang, X. & Roux, P.P. Regulation and function of the RSK family of protein kinases. Biochem. J. 441, 553-569 (2012).
34. Fukunaga, R. & Hunter, T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921-1933 (1997).
35. Waskiewicz, A.J., Flynn, A., Proud, C.G. & Cooper, J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909-1920 (1997).
36. Ueda, T. et al. Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc. Natl. Acad. Sci. USA 107, 13984-13990 (2010).
37. Okkenhaug, K., Bilancio, A., Emery, J.L. & Vanhaesebroeck, B. Phosphoinositide 3-kinase in T cell activation and survival. Biochem. Soc. Trans. 32, 332-335 (2004).
38. Costello, P.S., Gallagher, M. & Cantrell, D.A. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3, 1082-1089 (2002).
39. Harriague, J. & Bismuth, G. Imaging antigen-induced PI3K activation in T cells. Nat. Immunol. 3, 1090-1096 (2002).
40. Huppa, J.B., Gleimer, M., Sumen, C. & Davis, M.M. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4, 749-755 (2003).
41. Garçon, F. et al. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111, 1464-1471 (2008).
42. Calleja, V. et al. Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol. 5, e95 (2007).
43. Bayascas, J.R. et al. Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol. Cell. Biol. 28, 3258-3272 (2008).
44. Najafov, A., Shpiro, N. & Alessi, D.R. Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors. Biochem. J. 448, 285-295 (2012).
45. Sengupta, S., Peterson, T.R. & Sabatini, D.M. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40, 310-322 (2010).
46. García-Martínez, J.M. & Alessi, D.R. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem. J. 416, 375-385 (2008).
47. Heikamp, E.B. et al. The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. Nat. Immunol. 15, 457-464 (2014).
48. Wu, C. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513-517 (2013).
49. Kleinewietfeld, M. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518-522 (2013).
50. Delgoffe, G.M. et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295-303 (2011).
51. Waugh, C., Sinclair, L., Finlay, D., Bayascas, J.R. & Cantrell, D. Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol. Cell. Biol. 29, 5952-5962 (2009).
52. Sarbassov, D.D., Guertin, D.A., Ali, S.M. & Sabatini, D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (2005).
53. Barata, J.T. et al. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J. Exp. Med. 200, 659-669 (2004).
54. Cornish, G.H., Sinclair, L.V. & Cantrell, D.A. Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108, 600-608 (2006).
55. Brunn, G.J. et al. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15, 5256-5267 (1996).
56. Jacobs, M.D. et al. Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002. J. Biol. Chem. 280, 13728-13734 (2005).
57. Bain, J. et al. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315 (2007).
58. Macintyre, A.N. et al. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34, 224-236 (2011).
59. Eijkelenboom, A. & Burgering, B.M.T. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83-97 (2013).
60. Fabre, S. et al. FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J. Immunol. 181, 2980-2989 (2008).
61. Kerdiles, Y.M. et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10, 176-184 (2009).
62. Ouyang, W. et al. Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491, 554-559 (2012).
63. Ouyang, W., Beckett, O., Flavell, R.A. & Li, M.O. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30, 358-371 (2009).
64. Carlson, C.M. et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442, 299-302 (2006).
65. Finlay, D.K. et al. Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes. J. Exp. Med. 206, 2441-2454 (2009).
66. Preston, G.C., Feijoo-Carnero, C., Schurch, N., Cowling, V.H. & Cantrell, D.A. The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells. PLoS ONE 8, e77537 (2013).
67. Takada, K. et al. Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. J. Immunol. 186, 775-783 (2011).
68. Cyster, J.G. & Schwab, S.R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69-94 (2012).
69. Sinclair, L.V. et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 9, 513-521 (2008).
70. Hand, T.W. et al. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc. Natl. Acad. Sci. USA 107, 16601-16606 (2010).
71. Wang, R. & Green, D.R. Metabolic checkpoints in activated T cells. Nat. Immunol. 13, 907-915 (2012).
72. Marko, A.J., Miller, R.A., Kelman, A. & Frauwirth, K.A. Induction of glucose metabolism in stimulated T lymphocytes is regulated by mitogen-activated protein kinase signaling. PLoS ONE 5, e15425 (2010).
73. Carr, E.L. et al. Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J. Immunol. 185, 1037-1044 (2010).
74. Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882 (2011).
75. Sinclair, L.V. et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 10.1038/ni.2556 (2013).
76. Bar-Peled, L. & Sabatini, D.M. Regulation of mTORC1 by amino acids. Trends Cell Biol. (2014).
77. Dibble, C.C. & Manning, B.D. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat. Cell Biol. 15, 555-564 (2013).
78. Powell, J.D. & Delgoffe, G.M. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33, 301-311 (2010).
79. Ricoult, S.J.H. & Manning, B.D. The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep. 14, 242-251 (2013).
80. Kidani, Y. et al. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat. Immunol. 14, 489-499 (2013).
81. Finlay, D.K. et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441-2453 (2012).
82. Shi, L.Z. et al. HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376 (2011).
83. Wang, H. et al. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat. Immunol. 15, 393-401 (2014).
84. Shimobayashi, M. & Hall, M.N. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell Biol. 15, 155-162 (2014).
85. Cham, C.M. & Gajewski, T.F. Glucose availability regulates IFN production and p70S6 kinase activation in CD8+ effector T cells. J. Immunol. 174, 4670-4677 (2005).
86. Nakaya, M. et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity (2014).
87. Tamás, P. et al. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J. Exp. Med. 203, 1665-1670 (2006).
88. Hardie, D.G., Ross, F.A. & Hawley, S.A. AMP-activated protein kinase: a target for drugs both ancient and modern. Chem. Biol. 19, 1222-1236 (2012).
89. Tamás, P. et al. LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells. Eur. J. Immunol. 40, 242-253 (2010).
90. Rolf, J. et al. AMPKα1: A glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol. 43, 889-896 (2013).
91. Cai, S.-L. et al. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 173, 279-289 (2006).
92. Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771-785 (2014).
93. Yang, K., Neale, G., Green, D.R., He, W. & Chi, H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12, 888-897 (2011).
94. Efeyan, A. & Sabatini, D.M. Nutrients and growth factors in mTORC1 activation. Biochem. Soc. Trans. 41, 902-905 (2013).
95. Gwinn, D.M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226 (2008).
96. Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112 (2009).
97. Navarro, M.N., Goebel, J., Feijoo-Carnero, C., Morrice, N. & Cantrell, D.A. Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes. Nat. Immunol. 12, 352-361 (2011).
98. Ruperez, P., Gago-Martinez, A., Burlingame, A.L. & Oses-Prieto, J.A. Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeletal reorganization in early T cell receptor activation in human primary T cells. Mol. Cell. Proteomics 11, 171-186 (2012).
99. Mayya, V. et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal. 2, ra46 (2009).